Correction: Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361996/
https://www.ncbi.nlm.nih.gov/pubmed/32661117
http://dx.doi.org/10.1136/jitc-2019-000391corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361996/
https://www.ncbi.nlm.nih.gov/pubmed/32661117
http://dx.doi.org/10.1136/jitc-2019-000391corr1

Ejemplares similares